Computable drug discovery
Developing the Algorithms to Automate Drug Discovery
Our mission is to accelerate the transition to rational, computerized drug discovery via simulations and machine learning.
Computable drug discovery
Developing the Algorithms to Automate Drug Discovery
Our mission is to accelerate the transition to rational, computerized drug discovery via simulations and machine learning.
Computable drug discovery
Developing the Algorithms to Automate Drug Discovery
Our mission is to accelerate the transition to rational, computerized drug discovery via simulations and machine learning.
Some of Our Partners
mission
Accelerate the transition to rational, computerized drug discovery
In order to fulfill our vision, we work with our customers by becoming key technology partners, boosting their discovery workflow with the most innovative solutions.
Science, research, innovation, and development are the founding pillars of our company.
Science, research, innovation, and development are the founding pillars of our company.
Acellera at a glance
8,974
Papers citing Acellera's founders
832
Papers citing ACEMD software
16
Years of know-how in computational drug discovery
Acellera at a glance
Today, our software ACEMD has over 700 citations, and KDeep and Deepsite are among the most cited papers in the field of ML applied to drug discovery.
8,974
Papers citing Acellera's founders
832
Papers citing ACEMD software
16
Years of know-how in computational drug discovery
Learn More
Let's work together
Why Acellera
By partnering with Acellera, companies can leverage our innovative technology to transform drug discovery, reduce costs, and ultimately bring life-saving medications to market faster.
Licensing
Fees to use the platform with access to our datasets
Personalized maintenance
Development of tailored integrated solutions
Drug discovery services
Deliverable-based work orders
Using compute and Acellera’s technology
Focused on a specific problem for a few months
Platform development
Co-development and validation of key technologies
OpenScience, co-licensed
FTE for at least one year
Drug discovery partnerships
From target to investigational new drug (IND) applications
FTE, milestone payments and royalties
Experimental validation
Our platform
Accelerating innovation
Cutting-edge algorithms and machine learning techniques streamline and expedite the drug discovery process. Acellera's expertise in GPU-accelerated molecular dynamics and deep learning platforms enables more accurate and efficient drug design.
ACEMD platform
A software framework for molecular dynamics-based discovery. It's the most advanced molecular dynamics ecosystem for molecular simulations.
PlayMolecule molecular discovery platform
PlayMolecule is our computer aided drug discovery. PlayMolecule is a virtual environment for computable drug discovery where algorithms, data and computers are integrated to discover new knowledge.
